Carver Biosciences Competitors and Similar CompaniesClear all

Carver Biosciences's competitors and similar companies include Editas Medicine, Caribou Biosciences, Sana Biotechnology and Mirimus.
Carver Biosciences
Carver Biosciences
Carver Biosciences is a biotech company working on the development of antivirals.
Editas Medicine
Editas Medicine
Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.
Caribou Biosciences
Caribou Biosciences
Caribou Biosciences is a leading biotechnology company in genome engineering. We develop technology-based solutions for cellular.
Sana Biotechnology
Sana Biotechnology
Sana Biotechnology is a company specializing in cell and gene therapy.
Mirimus
Mirimus
Mirimus is a company that specializes in engineering customized mouse models with reversible gene silencing capability.
Founding Date
Founding Date
2022
Founding Date
2013
Founding Date
2011
Founding Date
2018
Founding Date
2010
Type
Type
Private
Type
Public
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
HQ
Locations
Cambridge, US HQ
Boulder, US
Cambridge, US
Locations
Berkeley, US HQ
Locations
Seattle, US HQ
Cambridge, US
South San Francisco, US
Locations
New York, US HQ
Employees
Employees
4
Employees
20816% increase
Employees
1631% increase
Employees
42110% increase
Employees
7113% decrease
Valuation ($)
Valuation ($)
N/A
Valuation ($)
665.6 m
Valuation ($)
611.1 m
Valuation ($)
1.9 b
Valuation ($)
N/A
Twitter followers
Twitter followers
12
Twitter followers
7.9 k
Twitter followers
6.3 k
Twitter followers
N/A
Twitter followers
727
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
19
Number of tweets (last 30 days)
8
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
9
Average likes per tweet (last 30 days)
11
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
94.74%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Employee Rating
Employee Rating
N/A
Employee Rating
3.2
Employee Rating
3.3
Employee Rating
3.6
Employee Rating
4

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$19.7m (FY, 2022)
Revenue (est.)
$13.9m (FY, 2022)
Revenue (est.)
N/A
Revenue (est.)
N/A
Net income
Net income
N/A
Net income
($220.4m) (FY, 2022)
Net income
($99.4m) (FY, 2022)
Net income
($269.5m) (FY, 2022)
Net income
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 210m
Total funding raised
$ 159.5m
Total funding raised
$ 700m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Editas Medicine
HQ
Cambridge, US
Employees
208↑ 16% increase

Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.

View company
Caribou Biosciences
HQ
Berkeley, US
Employees
163↑ 1% increase

Caribou Biosciences is a leading biotechnology company in genome engineering. We develop technology-based solutions for cellular.

View company
Sana Biotechnology
HQ
Seattle, US
Employees
421↑ 10% increase

Sana Biotechnology is a company specializing in cell and gene therapy.

View company
Mirimus
HQ
New York, US
Employees
71↓ 13% decrease

Mirimus is a company that specializes in engineering customized mouse models with reversible gene silencing capability.

View company